Colchicine in Patients With Coronary Artery Disease and Myocardial Infarction: A Narrative Review of Randomized Controlled Trials
Authors:
- Aaron SamuelsASAaron Samuels
- Areesha MoizAMAreesha Moiz
- Tetiana ZolotarovaTZTetiana Zolotarova
- Mark J. EisenbergMEMark J. Eisenberg
Open Access
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Targeting Inflammation After Acute Myocardial InfarctionJACC, 2025
- Colchicine in Coronary Artery Disease: A Contemporary Review of Evidence From Clinical Outcomes and Imaging TrialsThe American Journal of Cardiology, 2025
- Comparative effectiveness of sodium-glucose cotransporter 2 inhibitors along with colchicine versus colchicine alone among coronary artery disease and type 2 diabetes patientsProgress in Cardiovascular Diseases, 2025
- 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary SyndromesJACC, 2025
- Patterns and Prognostic Impact of Postdischarge Ischemic, Bleeding, and Heart Failure Events After Myocardial InfarctionThe American Journal of Cardiology, 2024
- Colchicine and cardiovascular preventionEuropean Journal of Internal Medicine, 2024
- Low-dose colchicine and high-sensitivity C-reactive protein after myocardial infarction: A combined analysis using individual patient data from the COLCOT and LoDoCo-MI studiesInternational Journal of Cardiology, 2022
- Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary SyndromeJACC, 2021
- Low-Dose Colchicine for Secondary Prevention of Cardiovascular DiseaseJACC, 2013
- Colchicine todayJoint Bone Spine, 2006